| Document And Entity Information | Nov. 12, 2024 |
| Document Information [Line Items] | |
| Entity Registrant Name | Atossa Therapeutics, Inc. |
| Document Type | 8-K |
| Document Period End Date | Nov. 12, 2024 |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-35610 |
| Entity Tax Identification Number | 26-4753208 |
| Entity Address, Address Line One | 10202 5th Avenue NE |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, City or Town | Seattle |
| Entity Address, State or Province | WA |
| Entity Address, Postal Zip Code | 98125 |
| City Area Code | 206 |
| Local Phone Number | 588-0256 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |
| Title of 12(b) Security | Common Stock |
| Trading Symbol | ATOS |
| Security Exchange Name | NASDAQ |
| Amendment Flag | false |
| Entity Central Index Key | 0001488039 |
